Alphabet's aging-research company applying deep biology and drug discovery to age-related disease.
Clinical-stage Swiss biotech developing small-molecule mitophagy inducers to treat age-related and chronic diseases.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →